Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 51 Fallopian Tube Neoplasms 28 Ovarian Neoplasms 23 Carcinoma, Non-Small-Cell Lung 22 Triple Negative Breast Neoplasms 15 Pancreatic Neoplasms 13 Breast Neoplasms, Male 11 Lung Neoplasms 10 Brenner Tumor 10 Inflammatory Breast Neoplasms 7 Uterine Cervical Neoplasms 5 Endometrial Adenocarcinoma 5 Adenocarcinoma of Lung 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Cholangiocarcinoma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Adenocarcinoma Of Esophagus 4 Pleural Effusion, Malignant 3 Pancreatic Adenocarcinoma 3 Neoplasms 3 Thymoma 2 Neurotoxicity Syndromes 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Breast Carcinoma In Situ 2

Interventions

Gemcitabine 14 Cisplatin 13 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 9 Paclitaxel 8 pembrolizumab 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Albumin-Bound Paclitaxel 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × Taxes × Clear all

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed

34 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡